Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Busulfan-induced hemorrhagic cystitis

R J Millard

    Urology
    |August 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Busulfan can cause hemorrhagic cystitis, a bladder condition that resolved after stopping the drug. Periodic urinary cytology is recommended for patients on long-term busulfan therapy due to cancer risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis.

    Current medical research and opinion·2006
    Same author

    Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

    BJU international·2004
    Same author

    Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen.

    Neurourology and urodynamics·2003
    Same author

    Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder.

    The Journal of urology·1999
    Same author

    The aging bladder: morphology and urodynamics.

    World journal of urology·1998
    Same author

    Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study.

    Neurourology and urodynamics·1998

    Area of Science:

    • Oncology
    • Urology
    • Pharmacology

    Background:

    • Busulfan is an alkylating agent used in chemotherapy.
    • Hemorrhagic cystitis is a serious bladder complication.
    • Understanding drug-induced toxicities is crucial for patient safety.

    Observation:

    • A case of hemorrhagic cystitis was observed in a patient treated with busulfan.
    • The condition showed spontaneous resolution upon discontinuation of busulfan therapy.
    • Histological examination revealed similarities to cystitis induced by radiation and cyclophosphamide.

    Findings:

    • Busulfan is a potential cause of hemorrhagic cystitis.
    • Cessation of busulfan leads to resolution of the condition.
    • Histological features of busulfan cystitis resemble those of radiation and cyclophosphamide-induced cystitis.

    Related Experiment Videos

    Implications:

    • Busulfan-induced hemorrhagic cystitis is a recognized clinical entity.
    • Discontinuation of busulfan may resolve hemorrhagic cystitis.
    • Periodic urinary cytology is advised for long-term busulfan therapy to monitor for atypia and potential malignancy.